Elevance Health Stock Today
ELV Stock | USD 403.60 6.12 1.54% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Elevance Health is selling for under 403.60 as of the 21st of November 2024; that is 1.54 percent increase since the beginning of the trading day. The stock's lowest day price was 397.74. Elevance Health has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on September 25, 2024, Representative William R Keating of US Congress acquired under $15k worth of Elevance Health's common stock.
Business Domain Health Care Equipment & Services | IPO Date 2nd of January 2001 | Category Healthcare | Classification Health Care |
It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana. Elevance Health operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. The company has 231.92 M outstanding shares of which 2.85 M shares are currently shorted by investors with about 1.44 days to cover. More on Elevance Health
Moving together with Elevance Stock
Moving against Elevance Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Fiscal Year End 22nd of January 2025
Elevance Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
CEO President | Gail Boudreaux | ||||
Thematic Idea | Insurance (View all Themes) | ||||
Old Name | PowerShares S&P Emerging Markets Low Volatility | ||||
Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, ARCA Institutional, Insurance, Health Care, Health Care Providers & Services, Healthcare Plans, Healthcare (View all Sectors) | ||||
Average Analyst Recommendation | |||||
Debt LevelsElevance Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Elevance Health's financial leverage. It provides some insight into what part of Elevance Health's total assets is financed by creditors.
|
Elevance Health (ELV) is traded on New York Stock Exchange in USA. It is located in 220 Virginia Avenue, Indianapolis, IN, United States, 46204 and employs 104,900 people. Elevance Health is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 92.18 B. Elevance Health runs under Health Care Providers & Services sector within Health Care industry. The entity has 231.92 M outstanding shares of which 2.85 M shares are currently shorted by investors with about 1.44 days to cover.
Elevance Health has about 7.39 B in cash with 8.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 150.32.
Check Elevance Health Probability Of Bankruptcy
Ownership AllocationElevance Health holds a total of 231.92 Million outstanding shares. The majority of Elevance Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Elevance Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Elevance Health. Please pay attention to any change in the institutional holdings of Elevance Health as this could imply that something significant has changed or is about to change at the company. Please note that on September 25, 2024, Representative William R Keating of US Congress acquired under $15k worth of Elevance Health's common stock.
Check Elevance Ownership Details
Elevance Stock Institutional Holders
Instituion | Recorded On | Shares | |
Norges Bank | 2024-06-30 | 3 M | |
Nuveen Asset Management, Llc | 2024-06-30 | 2.9 M | |
Baillie Gifford & Co Limited. | 2024-09-30 | 2.8 M | |
Alliancebernstein L.p. | 2024-06-30 | 2.8 M | |
Massachusetts Financial Services Company | 2024-09-30 | 2.4 M | |
Jpmorgan Chase & Co | 2024-06-30 | 2.4 M | |
Artisan Partners Limited Partnership | 2024-06-30 | 2.4 M | |
Legal & General Group Plc | 2024-06-30 | 2.2 M | |
Arnhold & S. Bleichroeder Advisers, Llc | 2024-09-30 | 2.2 M | |
Vanguard Group Inc | 2024-09-30 | 21.3 M | |
Blackrock Inc | 2024-06-30 | 20.7 M |
Elevance Health Historical Income Statement
Elevance Stock Against Markets
Elevance Health Corporate Management
Chris Rigg | SVP Division | Profile | |
Ronald Penczek | Controller VP | Profile | |
Scott Anglin | Treasurer SVP | Profile | |
John Gallina | Ex CFO | Profile | |
Julie Goon | Senior Affairs | Profile | |
Felicia Norwood | Executive Benefits | Profile | |
Charles Kendrick | Executive Benefits | Profile |
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.